|
An envelope http://www.mypersiansong.com/stmap_db5b0.html?fluconazole.ilosone.cialis.clarinex levothyroxine (t4) levothroid levoxyl synthroid tirosint unithroid MLM continued to generate positive free cash flow (FCF) during 2008-2011 despite the weak operating environment. The company was slightly FCF negative during 2012 ($2.1 million), which included about $35.1 million in business development expenses related to its hostile bid for Vulcan. For the LTM ending June 30, 2013, MLM generated $34.3 million of FCF. Fitch expects the company will generate between $40 million-$75 million of FCF during 2013.
|
